INTENDED FOR UK HEALTHCARE PROFESSIONALS
to the Fostair® (beclometasone and formoterol) section of the Chiesi Limited respiratory website for UK healthcare professionals.
Fostair® is available in a 100/6 and a 200/6 formulation.
Fostair® 100/6 is indicated for asthma and COPD (FEV1 < 50% predicted normal) in adults. Fostair® pMDI 100/6 can also be used as maintenance and reliever therapy (MART) in asthma.
Fostair® 200/6 is indicated for asthma in adults.
Both Fostair® 100/6 and 200/6 are available in pressurised metered dose inhalers (pMDI) and dry powder inhalers (DPI) Fostair® NEXThaler.
REGISTER FOR UPDATES
This website is updated on a regular basis. If you would like to be notified when new content is added, please sign up: